Search
for
Sort by
Research 181–210 of 1000+
- Polycystic ovary syndrome and impact on health
- Assessment of the obese patient
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook
- Menopause and aging, quality of life and sexuality
- STEROIDS AND STEROID-LIKE COMPOUNDS
- The therapeutic use of androgens in women
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Role of Zinc in Mucosal Health and Disease: A Review of Physiological, Biochemical, and Molecular Processes
- 5α-Reduced glucocorticoids: a story of natural selection
- Evidence-based approach to cutaneous hyperandrogenism in women
- Androgens and Antiandrogens
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Adiponectin Signaling Regulates Lipid Production in Human Sebocytes
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Acne in women
- Inducing hair follicle neogenesis with secreted proteins enriched in embryonic skin
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry